Myriad Genetics (MYGN) announced that the United States Patent ... MRD methods that are performed via an automation system configured to interface with laboratory equipment. U.S. patent No. 12,215,392 ...

SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Trilobio, developer of whole lab automation systems for biology research, introduced the first version of its comprehensive robotics, lab equipment and software platform.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...

Life Science Market Size and Growth 2025 to 2034The global life science market is expected to witness growth at a compound annual growth rate (CAGR) of 10.28% over the forecast period 2025 to ...

Precision, accuracy, and efficiency are the cornerstones of laboratory success, and emerging technologies are redefining how ...

It took more than 50 years for Marthe Gautier to set the record straight about her discovery of the genetic cause of Down ...

Medlab Middle East is rebranding to WHX Labs Dubai, marking the beginning of a new journey that reflects 24 years of success ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

The Noguchi Memorial Institute for Medical Research (NMIMR) has commissioned advanced equipment that would help in the study of cancer cells and other human cells ...

Mr Aedann See, 19, and his sister Deanna, 25, have both won the Molecular Frontiers Inquiry Prize. Read more at ...